A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Small animal PET with spontaneous inhalation of 15O-labelled oxygen gases: Longitudinal assessment of cerebral oxygen metabolism in a rat model of neonatal hypoxic-ischaemic encephalopathy
Tekijät: Shimochi Saeka, Ihalainen Jukka, Parikka Vilhelmiina, Kudomi Nobuyuki, Tolvanen Tuula, Hietanen Ari, Kokkomäki Esa, Johansson Stefan, Tsuji Masahiro, Kanaya Shigehiko, Yatkin Emrah, Grönroos Tove J., Iida Hidehiro
Julkaisuvuosi: 2023
Journal: Journal of Cerebral Blood Flow and Metabolism
Tietokannassa oleva lehden nimi: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Lehden akronyymi: J Cereb Blood Flow Metab
ISSN: 0271-678X
eISSN: 1559-7016
DOI: https://doi.org/10.1177/0271678X231220691
Verkko-osoite: https://journals.sagepub.com/doi/10.1177/0271678X231220691
Perinatal hypoxic-ischaemic encephalopathy (HIE) is the leading cause of irreversible brain damage resulting in serious neurological dysfunction among neonates. We evaluated the feasibility of positron emission tomography (PET) methodology with 15O-labelled gases without intravenous or tracheal cannulation for assessing temporal changes in cerebral blood flow (CBF) and cerebral metabolic rate for oxygen (CMRO2) in a neonatal HIE rat model. Sequential PET scans with spontaneous inhalation of 15O-gases mixed with isoflurane were performed over 14 days after the hypoxic-ischaemic insult in HIE pups and age-matched controls. CBF and CMRO2 in the injured hemispheres of HIE pups remarkably decreased 2 days after the insult, gradually recovering over 14 days in line with their increase found in healthy controls according to their natural maturation process. The magnitude of hemispheric tissue loss histologically measured after the last PET scan was significantly correlated with the decreases in CBF and CMRO2.This fully non-invasive imaging strategy may be useful for monitoring damage progression in neonatal HIE and for evaluating potential therapeutic outcomes.